Literature DB >> 24820188

First nationwide survey of US integrated 6-year cardiothoracic surgical residency program directors.

Amir H Lebastchi1, John J Tackett1, Michael Argenziano2, John H Calhoon3, Mario G Gasparri4, Michael E Halkos5, George L Hicks6, Mark D Iannettoni7, John S Ikonomidis8, Patrick M McCarthy9, Sandra L Starnes10, Betty C Tong11, David D Yuh12.   

Abstract

OBJECTIVE: The recently implemented integrated 6-year (I-6) format represents a significant change in cardiothoracic surgical residency training. We report the results of the first nationwide survey assessing I-6 program directors' impressions of this new format.
METHODS: A 28-question web-based survey was distributed to program directors of all 24 Accreditation Council for Graduate Medical Education-accredited I-6 training programs in November 2013. The response rate was a robust 67%.
RESULTS: Compared with graduates of traditional residencies, most I-6 program directors with enrolled residents believed that their graduates will be better trained (67%), be better prepared for new technological advances (67%), and have superior comprehension of cardiothoracic disease processes (83%). Just as with traditional program graduates, most respondents believed their I-6 graduates would be able to independently perform routine adult cardiac and general thoracic operations (75%) and were equivocal on whether additional specialty training (eg, minimally invasive, heart failure, aortic) was necessary. Most respondents did not believe that less general surgical training disadvantaged I-6 residents in terms of their career (83%); 67% of respondents would have chosen the I-6 format for themselves if given the choice. The greater challenges in training less mature and experienced trainees and vulnerability to attrition were noted as disadvantages of the I-6 format. Most respondents believed that I-6 programs represent a natural evolution toward improved residency training rather than a response to declining interest among medical school graduates.
CONCLUSIONS: High satisfaction rates with the I-6 format were prevalent among I-6 program directors. However, concerns with respect to training relatively less experienced, mature trainees were evident.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24820188      PMCID: PMC4336151          DOI: 10.1016/j.jtcvs.2014.04.004

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Integrated thoracic residency program applicants: the best and the brightest?

Authors:  Joanna Chikwe; Zachary Brewer; Andrew B Goldstone; David H Adams
Journal:  Ann Thorac Surg       Date:  2011-10-31       Impact factor: 4.330

2.  Six-year integrated cardiothoracic surgery residency applicants: characteristics, expectations, and concerns.

Authors:  Vakhtang Tchantchaleishvili; Bryan Barrus; Peter A Knight; Carolyn E Jones; Thomas J Watson; George L Hicks
Journal:  J Thorac Cardiovasc Surg       Date:  2013-10       Impact factor: 5.209

3.  Impact of a six-year integrated thoracic surgery training program at the Medical College of Wisconsin.

Authors:  Mario G Gasparri; William B Tisol; Saqib Masroor
Journal:  Ann Thorac Surg       Date:  2011-12-28       Impact factor: 4.330

4.  Comparison of cardiothoracic training curricula: integrated six-year versus traditional programs.

Authors:  Sarah T Ward; Danielle Smith; Adin-Cristian Andrei; George L Hicks; Richard J Shemin; John H Calhoon; Carolyn Reed; Edward D Verrier; David A Fullerton; Richard Lee
Journal:  Ann Thorac Surg       Date:  2013-04-18       Impact factor: 4.330

  4 in total
  1 in total

1.  Critical Comparison of the Quality and Content of Integrated Vascular Surgery, Thoracic Surgery, and Interventional Radiology Residency Training Program Websites: Qualitative Study.

Authors:  Katherine Jensen; Qi Yan; Mark G Davies
Journal:  JMIR Med Educ       Date:  2022-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.